There are many conditions that result in changes to the coagulation system, resulting in a propensity to bleed or a propensity to develop blood clots. Coagulo’s new approach to personalized coagulation phenotyping is propelling research and discovery to unlock the next generation of clinical treatments for patients requiring coagulation management.